Yannick Manigart - Gynecology

Author Information

Yannick Manigart is affiliated with the Department of Gynecology at Saint Pierre University Hospital, Université Libre de Bruxelles (ULB) - Free University of Brussels (ULB-VUB), Brussels, Belgium.

Research Contributions

Yannick Manigart has made significant contributions to the field of gynecology, particularly in the areas of cervical squamous intraepithelial lesions, human papillomavirus (HPV) infections, and reproductive health in HIV-positive individuals. His research includes studies on the management of high-grade cervical squamous intraepithelial lesions in HIV-positive women, the rarity of fetal cells in exocervical samples for noninvasive prenatal diagnosis, and the distribution of high-risk HPV genotypes in HIV-positive women. He has also investigated the efficacy of selective progestin receptor modulators and the outcomes of in vitro fertilization in couples where one or both partners are HIV-positive or infected with hepatitis C virus. Moreover, his work on the implementation of protocols and staff educational sessions has improved the care of survivors of sexual assault.

Aliases

Yannick Manigart is also known by the aliases Y. Manigart and Y Manigart.

Publication and Citation Metrics

Metric	Value
Total Citations	401
H-index	9
Total Papers	30

Publications:

Should the management of high grade cervical squamous intraepithelial lesion (HSIL) be different in HIV-positive women?

DOI: 10.1186/s12981-021-00371-x

Year: 2021

Rarity of fetal cells in exocervical samples for noninvasive prenatal diagnosis

DOI: 10.1515/jpm-2021-0291

Year: 2021

Implementation of a protocol and staff educational sessions improves the care of survivors of sexual assault.

DOI: 10.1016/J.MATURITAS.2019.03.004

Year: 2019

Cervical, anal and oral human papillomavirus (HPV) infection in young women: A case control study between women with perinatally HIV infection and women with non-perinatally HIV infection.

DOI: 10.1016/j.ejogrb.2019.11.022

Year: 2019

In vitro fertilization when men, women, or both partners are positive for HIV: a case–control study

DOI: 10.1007/s00404-017-4374-0

Year: 2017

The use of selective progestin receptor modulators (SPRMs) and more specifically ulipristal acetate in the practice of gynaecology

DOI: 10.1111/ajo.12641

Year: 2017

In vitro fertilization for women infected by hepatitis C virus: a matched case-control study and a systematic literature review

DOI: 10.1007/s10815-017-0892-8

Year: 2017

[State of contraception in 2016].

DOI:

Year: 2016

High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus

DOI: 10.1097/QAD.0000000000000929

Year: 2016

Etat de la contraception en 2016

DOI:

Year: 2016

What is Prothrombin Time?

What Types of Data are Covered?

What are Uterine Anomalies?

Can Cycling Cause Urinary Tract Infections (UTIs)?

How do EDCs Affect Reproductive Health?

What Role Does Yoga Play in Gynecology?

How Can Genetic Testing Help in Gynecology?

Who Is Eligible for These Programs?

How can gynecological practices ensure continuous improvement?

How do insurance policies affect the cost of gynecological care?

Partnered Content Networks

Relevant Topics